M3 Inc (MTHRY)
4.69
+0.01
(+0.21%)
USD |
OTCM |
Jun 17, 16:00
M3 Enterprise Value: 5.401B for June 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 17, 2024 | 5.401B |
| June 14, 2024 | 5.388B |
| June 13, 2024 | 5.510B |
| June 12, 2024 | 5.632B |
| June 11, 2024 | 5.591B |
| June 10, 2024 | 5.713B |
| June 07, 2024 | 5.931B |
| June 06, 2024 | 5.999B |
| June 05, 2024 | 6.229B |
| June 04, 2024 | 6.107B |
| June 03, 2024 | 5.937B |
| May 31, 2024 | 5.564B |
| May 30, 2024 | 5.469B |
| May 29, 2024 | 5.306B |
| May 28, 2024 | 5.591B |
| May 24, 2024 | 5.713B |
| May 23, 2024 | 5.713B |
| May 22, 2024 | 5.822B |
| May 21, 2024 | 5.808B |
| May 20, 2024 | 5.958B |
| May 17, 2024 | 5.993B |
| May 16, 2024 | 6.162B |
| May 15, 2024 | 6.297B |
| May 14, 2024 | 6.229B |
| May 13, 2024 | 6.039B |
| Date | Value |
|---|---|
| May 10, 2024 | 6.012B |
| May 09, 2024 | 6.392B |
| May 08, 2024 | 6.311B |
| May 07, 2024 | 6.406B |
| May 06, 2024 | 6.311B |
| May 03, 2024 | 6.297B |
| May 02, 2024 | 6.149B |
| May 01, 2024 | 6.026B |
| April 30, 2024 | 6.175B |
| April 29, 2024 | 6.773B |
| April 26, 2024 | 6.841B |
| April 25, 2024 | 7.112B |
| April 24, 2024 | 7.275B |
| April 23, 2024 | 7.357B |
| April 22, 2024 | 7.180B |
| April 19, 2024 | 6.854B |
| April 18, 2024 | 7.212B |
| April 17, 2024 | 7.248B |
| April 16, 2024 | 7.479B |
| April 15, 2024 | 7.262B |
| April 12, 2024 | 7.574B |
| April 11, 2024 | 7.696B |
| April 10, 2024 | 7.846B |
| April 09, 2024 | 8.063B |
| April 08, 2024 | 8.212B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.306B
Minimum
May 29 2024
70.29B
Maximum
Jan 08 2021
26.98B
Average
20.55B
Median
Sep 14 2022
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co Ltd | 70.21B |
| Nxera Pharma Co Ltd | 1.034B |
| PeptiDream Inc | 1.677B |
| Healios KK | 83.91M |
| AnGes Inc | 59.01M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 58.33M |
| Revenue (Quarterly) | 402.20M |
| Total Expenses (Quarterly) | 342.97M |
| EPS Diluted (Quarterly) | 0.0429 |
| Gross Profit Margin (Quarterly) | 56.39% |
| Profit Margin (Quarterly) | 14.50% |
| Earnings Yield | 4.93% |
| Operating Earnings Yield | 6.88% |
| Normalized Earnings Yield | 4.932 |